Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot, Jérémy Manry, Eleftherios Michailidis, Hans-Heinrich Hoffmann, Shohei Eto, Marina García-Prat, Lucy Bizien, Alba Parra-Martínez · 2021

Read Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths by Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot, Jérémy Manry, Eleftherios Michailidis, Hans-Heinrich Hoffmann, Shohei Eto, Marina García-Prat, Lucy Bizien, Alba Parra-Martínez (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w3195130348.txt.

Description

Paul Bastard, Adrian Gervais, Tom Le Voyer, and colleagues report on harmful autoantibodies in COVID-19, in Science Immunology in 2021. Autoantibodies are immune proteins that attack the body's own defences. Here they block type I interferons, signals that help fight viruses early in infection. Earlier work had linked these blockers to life-threatening COVID-19 pneumonia in some patients.

The team reports that about four in a hundred uninfected people over seventy carry these autoantibodies. As the title states, they account for about a fifth of COVID-19 deaths. Their share rises steeply with age, which helps explain why older people face far greater risk. Testing for them could flag patients who need early, close care.

Catalog record

CREATORPaul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot, Jérémy Manry, Eleftherios Michailidis, Hans-Heinrich Hoffmann, Shohei Eto, Marina García-Prat, Lucy Bizien, Alba Parra-Martínez
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE226 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEOpenAlex / Science Immunology

Source: https://doi.org/10.1126/sciimmunol.abl4340

Browse the full library · About the Tower of Babel